<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE ArticleSet PUBLIC "-//NLM//DTD PubMed 2.7//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/in/PubMed.dtd">
<ArticleSet>
<Article>
<Journal>
				<PublisherName>West Asia Organization for Cancer Prevention (WAOCP), APOCP's West Asia Chapter.</PublisherName>
				<JournalTitle>Asian Pacific Journal of Cancer Prevention</JournalTitle>
				<Issn>1513-7368</Issn>
				<Volume>25</Volume>
				<Issue>2</Issue>
				<PubDate PubStatus="epublish">
					<Year>2024</Year>
					<Month>02</Month>
					<Day>01</Day>
				</PubDate>
			</Journal>
<ArticleTitle>High Expression of PXMP4 in Hepatocellular Carcinoma Tissues</ArticleTitle>
<VernacularTitle></VernacularTitle>
			<FirstPage>603</FirstPage>
			<LastPage>608</LastPage>
			<ELocationID EIdType="pii">91022</ELocationID>
			
<ELocationID EIdType="doi">10.31557/APJCP.2024.25.2.603</ELocationID>
			
			<Language>EN</Language>
<AuthorList>
<Author>
					<FirstName>Ming Ming </FirstName>
					<LastName>Zhao</LastName>
<Affiliation>Faculty of Medicine, Lincoln University College, Malaysia.</Affiliation>

</Author>
<Author>
					<FirstName>Zarina </FirstName>
					<LastName>Awang</LastName>
<Affiliation>Faculty of Medicine, Lincoln University College, Malaysia.</Affiliation>

</Author>
<Author>
					<FirstName>Farra Aidah Binti</FirstName>
					<LastName>Jumuddin</LastName>
<Affiliation>Faculty of Medicine, Lincoln University College, Malaysia.</Affiliation>
<Identifier Source="ORCID">0000-0002-3817-7050</Identifier>

</Author>
</AuthorList>
				<PublicationType>Journal Article</PublicationType>
			<History>
				<PubDate PubStatus="received">
					<Year>2023</Year>
					<Month>10</Month>
					<Day>03</Day>
				</PubDate>
			</History>
		<Abstract>Objective: To analyze the high expression of peroxisome membrane protein 4 (PXMP4) in hepatocellular carcinoma (HCC) and its clinical significance. Methods:The expression of PXMP4 mRNA in HCC tissues and corresponding adjacent tissues was detected by Q-PCR, and the expression of PXMP4 protein was detected by Western blot and immunohistochemistry. The correlation of PXMP4 protein expression with clinicopathological features and prognosis of HCC was analyzed. Results: The expression levels of PXMP4 mRNA and protein in HCC tissues were significantly higher than those in adjacent tissues (P &lt; 0.05), and its high expression was significantly correlated with tumor differentiation, lymph node metastasis, depth of invasion and TNM stage (P &lt; 0.05). Patients with high expression of PXMP4 had a poor prognosis (P &lt; 0.05). Conclusion: The high expression of PXMP4 may promote the occurrence and development of HCC, and inhibition of PXMP4 may be one of the potential molecular targets for targeted therapy of HCC.</Abstract>
		<ObjectList>
			<Object Type="keyword">
			<Param Name="value">Keywords: Hepatocellular Carcinoma</Param>
			</Object>
			<Object Type="keyword">
			<Param Name="value">PXMP4</Param>
			</Object>
			<Object Type="keyword">
			<Param Name="value">Prognosis</Param>
			</Object>
		</ObjectList>
<ArchiveCopySource DocType="pdf">https://journal.waocp.org/article_91022_fb8913473114cd2f7905be55437c515a.pdf</ArchiveCopySource>
</Article>
</ArticleSet>
